Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

535262

registered interest
date	11/07/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people were diagnosed with cancer as a result of exposure to acetaldehyde in the (a) North East and (b) UK in the latest period for which figures are available.
tabling member constituency	Redcar
tabling member printed	Anna Turley
uin	42411
answer	answer is ministerial correction date of answer 14/07/2016 answer text <p>Information concerning the number of people diagnosed with cancer as a result of exposure to acetaldehyde is not available.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/07/2016 07:42:02 answering member 3918 label Biography information for Jane Ellison
tabling member	4449 label Biography information for Anna Turley

523070

registered interest
date	06/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on the average waiting time between cancer referral and diagnosis in each of the last 10 years.
tabling member constituency	Copeland
tabling member printed	Mr Jamie Reed
uin	39298
answer	answer is ministerial correction date of answer 14/06/2016 answer text <p>The Department does not hold data on the average waiting time between cancer referral and diagnosis. NHS England collects data on cancer waiting times and these data are published on their website. The data comprise of organisational performance against operational standards that support waiting time commitments laid out in the NHS Constitution. These include the standard that 93% of patients should be seen by a specialist within a maximum of two weeks from urgent general practitioner (GP) referral where cancer is suspected. There are seven other cancer waiting time standards, but not one that measures waiting time between referral and diagnosis.</p><p> </p><p>A national time series can be found at the link below:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2015/02/Cancer-Waiting-Times-National-Time-Series-Oct-2009-Mar-2016-Provider-based.xlsx" target="_blank">https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2015/02/Cancer-Waiting-Times-National-Time-Series-Oct-2009-Mar-2016-Provider-based.xlsx</a></p><p> </p><p>The Independent Cancer Taskforce’s cancer strategy for 2015-2020 recommended a new standard that patients should be diagnosed with cancer, or have cancer excluded, within 28 days of being referred by their GP. Test sites for this new standard are in the process of being identified.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/06/2016 15:09:46 answering member 3918 label Biography information for Jane Ellison
tabling member	1503 label Biography information for Mr Jamie Reed

523076

registered interest
date	06/06/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on the average waiting time between cancer diagnosis and treatment in each of the last 10 years.
tabling member constituency	Copeland
tabling member printed	Mr Jamie Reed
uin	39311
answer	answer is ministerial correction date of answer 09/06/2016 answer text <p>The Department does not hold data on the average waiting time between cancer diagnosis and treatment. NHS England collects data on cancer waiting times and these data are published on their website. The data comprise of organisational performance against operational standards that support waiting time commitments laid out in the NHS Constitution. These include the standard that 96% of patients should begin first definitive treatment for all cancers within a maximum of 31 days from diagnosis.</p><p> </p><p>A national time series can be found at the link below:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2015/02/Cancer-Waiting-Times-National-Time-Series-Oct-2009-Mar-2016-Provider-based.xlsx" target="_blank">https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2015/02/Cancer-Waiting-Times-National-Time-Series-Oct-2009-Mar-2016-Provider-based.xlsx</a></p> answering member constituency Battersea answering member printed Jane Ellison question first answered 09/06/2016 15:13:35 answering member 3918 label Biography information for Jane Ellison
tabling member	1503 label Biography information for Mr Jamie Reed

521287

registered interest
date	24/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what additional funding his Department plans to make available for implementation of the recommendations of the Independent Cancer Taskforce.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	38174
answer	answer is ministerial correction date of answer 02/06/2016 answer text <p>By 2020-21, the Government will increase funding for the National Health Service by £10 billion a year in real terms compared with 2014-15, to support the implementation of the NHS’s own plan - the NHS Five Year Forward View - to transform services across the country. The Government is backing the NHS plan and enabling it to go further – by investing £2 billion more than the £8 billion the NHS asked for – delivering government objectives including improved access to cancer treatments.</p><p>As part of the response to the independent Cancer Taskforce’s recommendations, in September 2015, we announced funding of up to £300 million a year by 2020 to increase diagnostic capacity to meet the new target that patients will be given a definitive cancer diagnosis, or the all clear, within 28 days of being referred by a general practitioner.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 02/06/2016 15:29:57 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

520834

registered interest
date	23/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to reduce the financial burden on people with cancer which arises from their condition and affects their ability to recover.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	38013
answer	answer is ministerial correction date of answer 01/06/2016 answer text <p>In its report <em>Achieving World Class Cancer Outcomes: A Strategy for England 2015-2020</em> (July 2015), the independent Cancer Taskforce called for an acceleration of the commissioning and provision of services to support people affected by cancer to live as healthy and as happy lives as possible. Over the last few years, NHS England has been working with Macmillan Cancer Support to roll out the Recovery Package, which describes a set of actions that ensure that the individual needs of all people going through cancer treatment and beyond are met by tailored support and services. By working through a Recovery Package, patients and clinicians assess patients’ holistic needs and plan appropriately for their care and support. They ensure that a treatment summary is sent between a patient’s hospital and their general practitioner (GP), that they are appropriately followed up by their GP, and can attend health and wellbeing events for patients and carers.</p><p>In September 2015, we announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. In April 2016, NHS England published guidance on the commissioning of these services to support people living with and beyond cancer, and will continue to support both Sustainability and Transformation Plan footprints and clinical commissioning groups to put this guidance into action. Support for patients living with and beyond cancer should be tailored specifically to the needs of every patient, including to access the financial support they need.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 01/06/2016 13:22:26 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy

519189

registered interest
date	18/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to his Department's news story of 13 September 2015, From 2020 people with suspected cancer will be diagnosed faster, when his Department plans to make tailored recovery packages available for cancer patients, including those with rarer cancers.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	37113
answer	answer is ministerial correction date of answer 23/05/2016 answer text <p>In its report <em>Achieving World Class Cancer Outcomes: A Strategy for England 2015-2020</em> (July 2015), the independent Cancer Taskforce called for an acceleration of the commissioning and provision of services to support people affected by cancer to live as healthy and as happy lives as possible. Over the last few years, NHS England has been working with Macmillan Cancer Support to roll out the Recovery Package, which describes a set of actions that ensure that the individual needs of all people going through cancer treatment and beyond, including rare cancers, are met by tailored support and services. By working through a Recovery Package, patients and clinicians assess patients’ holistic needs and plan appropriately for their care and support, they ensure that a treatment summary is sent between a patient’s hospital and their general practitioner (GP), that they are appropriately followed up by their GP, and can attend health and wellbeing events for patients and carers.</p><p>In September 2015, the Department announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. In April 2016, NHS England published guidance on the commissioning of these services to support people living with and beyond cancer, and will continue to support both Sustainability and Transformation Plan footprints and clinical commissioning groups to put this guidance into action.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 37293 question first answered 23/05/2016 10:35:36 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

519227

registered interest
date	18/05/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to his Department's news story of 13 September 2015, entitled From 2020, people with suspected cancer will be diagnosed faster, by what date he expects tailored recovery packages to be available for (a) all cancer patients and (b) patients with rarer cancers.
tabling member constituency	Basildon and Billericay
tabling member printed	Mr John Baron
uin	37293
answer	answer is ministerial correction date of answer 23/05/2016 answer text <p>In its report <em>Achieving World Class Cancer Outcomes: A Strategy for England 2015-2020</em> (July 2015), the independent Cancer Taskforce called for an acceleration of the commissioning and provision of services to support people affected by cancer to live as healthy and as happy lives as possible. Over the last few years, NHS England has been working with Macmillan Cancer Support to roll out the Recovery Package, which describes a set of actions that ensure that the individual needs of all people going through cancer treatment and beyond, including rare cancers, are met by tailored support and services. By working through a Recovery Package, patients and clinicians assess patients’ holistic needs and plan appropriately for their care and support, they ensure that a treatment summary is sent between a patient’s hospital and their general practitioner (GP), that they are appropriately followed up by their GP, and can attend health and wellbeing events for patients and carers.</p><p>In September 2015, the Department announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. In April 2016, NHS England published guidance on the commissioning of these services to support people living with and beyond cancer, and will continue to support both Sustainability and Transformation Plan footprints and clinical commissioning groups to put this guidance into action.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 37113 question first answered 23/05/2016 10:35:36 answering member 3918 label Biography information for Jane Ellison
tabling member	1390 label Biography information for Mr John Baron

442341

registered interest
date	04/01/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to respond to the report of the Independent Cancer Taskforce; and what the timetable is for implementation of the recommendations of that report.
tabling member constituency	Lewes
tabling member printed	Maria Caulfield
uin	20761
answer	answer is ministerial correction date of answer 12/01/2016 answer text <p>The independent Cancer Taskforce’s five-year strategy for cancer, <em>Achieving World-Class Cancer Outcomes</em>, published in July 2015, recommends improvements across the cancer pathway with the aim of improving survival rates. NHS England has appointed Cally Palmer as NHS National Cancer Director. She will lead on the implementation of the strategy, as well as new cancer vanguards to redesign care and patient experience.</p><br /><p>She is currently setting up a new Cancer Transformation Board to lead the roll-out of the recommendations of the new strategy, and a Cancer Advisory Group, chaired by Dr Harpal Kumar, Chief Executive of Cancer Research UK, will oversee and scrutinise their work. Timeframes and phasing for implementation will be dependent on the final financial settlement reached as a result of the spending review.</p><br /><p>We announced in September 2015 that Health Education England (HEE) is developing a new national training programme for an additional 200 staff to get the skills and expertise to carry out endoscopies by 2018. The content of the next mandate from the Government to HEE is currently being determined.</p><br /><p>A commitment to whole-person care for patients, including those living with and beyond cancer, is embedded throughout the cancer taskforce report. In addition, the cancer vanguards have been established to explore new models of care, with a focus on delivering more person-centred care.</p><br /><p>Ensuring the National Health Service is able to support the availability and use of effective treatments and medicines for rare cancers is a key priority. Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce’s report made many recommendations relevant to rarer cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments.</p><br /> <br /> <br /> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 20760 20762 20763 20764 question first answered 12/01/2016 11:47:16 answering member 3918 label Biography information for Jane Ellison
tabling member	4492 label Biography information for Maria Caulfield

442342

registered interest
date	04/01/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with (a) NHS England and (b) Health Education England on the strategic review of the cancer workforce recommended in the report of the Independent Cancer Taskforce.
tabling member constituency	Lewes
tabling member printed	Maria Caulfield
uin	20762
answer	answer is ministerial correction date of answer 12/01/2016 answer text <p>The independent Cancer Taskforce’s five-year strategy for cancer, <em>Achieving World-Class Cancer Outcomes</em>, published in July 2015, recommends improvements across the cancer pathway with the aim of improving survival rates. NHS England has appointed Cally Palmer as NHS National Cancer Director. She will lead on the implementation of the strategy, as well as new cancer vanguards to redesign care and patient experience.</p><br /><p>She is currently setting up a new Cancer Transformation Board to lead the roll-out of the recommendations of the new strategy, and a Cancer Advisory Group, chaired by Dr Harpal Kumar, Chief Executive of Cancer Research UK, will oversee and scrutinise their work. Timeframes and phasing for implementation will be dependent on the final financial settlement reached as a result of the spending review.</p><br /><p>We announced in September 2015 that Health Education England (HEE) is developing a new national training programme for an additional 200 staff to get the skills and expertise to carry out endoscopies by 2018. The content of the next mandate from the Government to HEE is currently being determined.</p><br /><p>A commitment to whole-person care for patients, including those living with and beyond cancer, is embedded throughout the cancer taskforce report. In addition, the cancer vanguards have been established to explore new models of care, with a focus on delivering more person-centred care.</p><br /><p>Ensuring the National Health Service is able to support the availability and use of effective treatments and medicines for rare cancers is a key priority. Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce’s report made many recommendations relevant to rarer cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments.</p><br /> <br /> <br /> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 20760 20761 20763 20764 question first answered 12/01/2016 11:47:16 answering member 3918 label Biography information for Jane Ellison
tabling member	4492 label Biography information for Maria Caulfield

442343

registered interest
date	04/01/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government plans to take to support whole person care across the cancer pathway over the next 15 years.
tabling member constituency	Lewes
tabling member printed	Maria Caulfield
uin	20763
answer	answer is ministerial correction date of answer 12/01/2016 answer text <p>The independent Cancer Taskforce’s five-year strategy for cancer, <em>Achieving World-Class Cancer Outcomes</em>, published in July 2015, recommends improvements across the cancer pathway with the aim of improving survival rates. NHS England has appointed Cally Palmer as NHS National Cancer Director. She will lead on the implementation of the strategy, as well as new cancer vanguards to redesign care and patient experience.</p><br /><p>She is currently setting up a new Cancer Transformation Board to lead the roll-out of the recommendations of the new strategy, and a Cancer Advisory Group, chaired by Dr Harpal Kumar, Chief Executive of Cancer Research UK, will oversee and scrutinise their work. Timeframes and phasing for implementation will be dependent on the final financial settlement reached as a result of the spending review.</p><br /><p>We announced in September 2015 that Health Education England (HEE) is developing a new national training programme for an additional 200 staff to get the skills and expertise to carry out endoscopies by 2018. The content of the next mandate from the Government to HEE is currently being determined.</p><br /><p>A commitment to whole-person care for patients, including those living with and beyond cancer, is embedded throughout the cancer taskforce report. In addition, the cancer vanguards have been established to explore new models of care, with a focus on delivering more person-centred care.</p><br /><p>Ensuring the National Health Service is able to support the availability and use of effective treatments and medicines for rare cancers is a key priority. Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce’s report made many recommendations relevant to rarer cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments.</p><br /> <br /> <br /> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 20760 20761 20762 20764 question first answered 12/01/2016 11:47:16 answering member 3918 label Biography information for Jane Ellison
tabling member	4492 label Biography information for Maria Caulfield